Global biopharmaceutical company
Maintain access to mental health medications for the low-income subsidy (LIS) eligible population under Medicare Part D in prescription drug reform legislation (S. 2543, Prescription Drug Pricing Reduction Act; H.R. 3, Lower Drug Costs Now Act) Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings;
FY2020 appropriations for Labor-HHS, CJS and Interior (Indian Health Service) bills Awareness of the need for access to all FDA-approved medications

Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments

Initiatives to promote the use of relapse prevention post detoxification
MMM - Medicare/Medicaid ALC - Alcohol and Drug Abuse HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SPLITOAK STRATEGIES LLC
300 New Jersey Avenue, NW, Suite 900, Washington, DC, 20001, US
SARAH KUEHL EGGE SARAH KUEHL EGGE (1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction) SARAH KUEHL EGGE
1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction